Sponsors (10)
The resolution preserves no‑cost access to evidence-based preventive services and improves procedural transparency for the Task Force, but funding/staffing shortfalls, canceled meetings, and expanded appointment authority risk delays and potential politicization of recommendations.
Patients (including those with chronic conditions and Medicare/Medicaid beneficiaries) keep access to evidence-based preventive services graded A or B without in‑network cost-sharing, reducing out-of-pocket costs for screenings and prevention.
Maintaining an independent, methodical U.S. Preventive Services Task Force supports higher-quality, evidence-based screening and prevention recommendations that can reduce disease burden and save lives.
Clarifying appointment terms and conflict-of-interest rules for Task Force members promotes transparency and trust in who develops preventive care recommendations.
Reduced AHRQ funding and staffing has weakened support for the Task Force, risking slower evidence reviews and delayed preventive recommendations that can postpone coverage and access to no‑cost services.
Affirming the Secretary's authority to appoint, remove, and review Task Force members raises concerns about potential political influence over preventive care recommendations, undermining perceived independence.
Abrupt cancellation of scheduled Task Force meetings can delay formal votes and issuance or finalization of recommendations, slowing coverage updates for patients who rely on timely preventive guidance.
Based on analysis of 2 sections of legislative text.
Records findings about the Task Force’s role, methods, appointment rules, and concerns over AHRQ staffing cuts and a canceled meeting that impaired its work.
Introduced July 29, 2025 by Angus Stanley King · Last progress July 29, 2025
Affirms and records findings about the U.S. Preventive Services Task Force, describing its scientific independence, membership rules, review methods, public comment process, and the legal effect of its A/B preventive-service recommendations under the Affordable Care Act. Notes that recent reductions in AHRQ staffing and funding have weakened support for the Task Force and that a July 2025 cancellation of a scheduled meeting prevented a formal vote on recommendations.